Fig. 1 · Structure
Documents & Downloads
Ibrolipim
LPL Activator
Ibrolipim is an orally active lipoprotein lipase (LPL) activator that effectively decreases plasma triglyceride levels while promoting an increase in high-density lipoprotein cholesterol. Its biological activity includes renoprotective and hypolipidemic effects, making it a valuable tool for research into metabolic disorders and cardiovascular health. Ibrolipim is utilized in studies exploring lipid metabolism and its implications for diseases associated with dyslipidemia.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Activator |
| CAS Number | 133208-93-2 |
| Applications | LPL Activator |
| Formula | C19H20BrN2O4P |
| Molecular Weight | 451.25 |
| Synonyms | NO-1886 |
| SMILES | BrC1=CC(C#N)=C(C=C1)NC(C2=CC=C(C=C2)CP(OCC)(OCC)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.